Teladoc Health, Inc. (TDOC) NYSE

8.23

-0.13(-1.56%)

Updated at October 29 04:00PM

Currency In USD

Valuation

Market Cap1.55B
Enterprise Value1.84B
P/E Ratio-6.47
PEG Ratio0.97
Price/Sales Ratio0.58
Price/Book Ratio1.04
Enterprise/Revenue0.7
Enterprise/EBITDA-12.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.09
Operating Margin-0.11

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.16

Income Statement

Revenue2.57B
Revenue/Share14.39
Gross Profit1.82B
EBITDA-587.01M
Net Income-1B
Diluted EPS-5.87

Balance Sheet

Total Cash726.25M
Total Cash/Share4.13
Total Debt1.03B
Total Debt/Equity0.74
Current Ratio2.7
Book Value Per Share7.92

Price History

52-Week Change-7.11
52-Week High15.21
52-Week Low6.35
Moving Average 50 Days8.17
Moving Average 200 Days8.35

Statistics

Average Volume7.17M
Shares Outstanding176.69M
% Held by Institutions69.29

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A